Oxford RECOVERY Evaluation of COVID-19 Therapy Flawed Against Hydroxychloroquine and Dangerous to Patients
Note: this article is dated March 28, just days after the RECOVERY trial was announced. See linked below the follow up to this article, dated
Search Results for: EARLY
New French Study Confirms Efficacy of Hydroxychloroquine / Azithromycin Treatment
“In conclusion, we confirm the efficacy of hydroxychloroquine associated with azithromycin in the treatment of COVID-19 and its potential effectiveness in the early impairment of
Coronavirus: Treatment is on its Way
by Jean-Pierre Kiekens – Oxford trained economist and former lecturer at the University of Brussels. The author also holds a degree in bio-engineering / agronomy
Coronavirus: What is at Stake, and How to Deal with It?
« If you fail to prepare, you are preparing to fail » — In the wake of a likely global pandemic, never this say may have
